Prothena Corp Public (PRTA) Net Cash Flow Growth (3y) (2015 - 2026)
Prothena Corp Public (PRTA) Net Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Prothena Corp Public | 483.37 Mn | 153.91 Mn | - | 42.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.69% |
| Dec 31, 2025 | -28.22% |
| Sep 30, 2025 | -45.54% |
| Jun 30, 2025 | -10.78% |
| Mar 31, 2025 | -13.98% |
| Dec 31, 2024 | -31.60% |
| Sep 30, 2024 | -30.56% |
| Jun 30, 2024 | -34.11% |
| Mar 31, 2024 | -52.10% |
| Dec 31, 2023 | -39.58% |
| Sep 30, 2023 | 37.63% |
| Jun 30, 2023 | -13.04% |
| Mar 31, 2023 | -1.68% |
| Dec 31, 2022 | 156.06% |
| Sep 30, 2022 | -12.73% |
| Jun 30, 2022 | -41.93% |
| Mar 31, 2022 | -27.17% |
| Dec 31, 2021 | 4.15% |
| Sep 30, 2021 | 97.74% |
| Jun 30, 2021 | -0.20% |